Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier Formulations
Current dry powder formulations for inhalation deposit a large fraction of their emitted dose in the upper respiratory tract where they contribute to off-target adverse effects and variability in lung delivery. The purpose of the current study is to design a new formulation concept that more effecti...
Saved in:
Main Authors: | Danforth P. Miller, Thomas E. Tarara, Jeffry G. Weers |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f88f6d36841c437f9e8e7cbd4ec111e4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the Importance of Capsules in Dry Powder Inhalers
by: Francesca Buttini, et al.
Published: (2021) -
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
by: Priyadarshini Kachroo, et al.
Published: (2021) -
Estrategia terapéutica para prevenir la remodelación de las vías aéreas
by: Carrasco C.,Edgardo
Published: (2004) -
Effect of Inhaled Corticosteroids on Blood Glucose Homeostasis in Asthmatic Children
by: Alshaimaa Essam, et al.
Published: (2020) -
Evaluación de las técnicas y errores en el uso de los inhaladores de dosis medida en el paciente adulto
by: Sotomayor L,Hernán, et al.
Published: (2001)